Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min-Gi Kim

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Cell Biochemistry and Function|September 11, 2019
Suppression of PRPF4 regulates pluripotency, proliferation, and differentiation in mouse embryonic stem cellsSong Park, Se-Hyeon Han, Hyeon-Gyeom Kim, et al.
Molecular and Cellular Probes|August 26, 2019
PRPF4 is a novel therapeutic target for the treatment of breast cancer by influencing growth, migration, invasion, and apoptosis of breast cancer cells via p38 MAPK signaling pathwaySong Park, Se-Hyeon Han, Hyeon-Gyeom Kim, et al.
BMC Pharmacology & Toxicology|July 28, 2016
Placental transfer and mammary excretion of a novel angiotensin receptor blocker fimasartan in ratsTae Hwan Kim, Min Gi Kim, Soyoung Shin, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 15, 2021
Administration in fed state but not controlled release in the colon increases oral bioavailability of DF030263, a promising drug candidate for chronic lymphocytic leukemiaJong Bong Lee, Xiaowei Zang, Atheer Zgair, et al.
Drug Delivery|June 13, 2018
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancerGa Hee Kim, Ji Eun Won, Yeongseon Byeon, et al.
Scientific Reports|December 3, 2016
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapyHee Dong Han, Yeongseon Byeon, Jong-Hwa Jang, et al.
Cancer Research|August 18, 2018
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian CancerYeongseon Byeon, Jeong-Won Lee, Whan Soo Choi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 18, 2018
Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic systemJong Bong Lee, Atheer Zgair, Jed Malec, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Cell Biochemistry and Function|September 11, 2019
Suppression of PRPF4 regulates pluripotency, proliferation, and differentiation in mouse embryonic stem cellsSong Park, Se-Hyeon Han, Hyeon-Gyeom Kim, et al.
Molecular and Cellular Probes|August 26, 2019
PRPF4 is a novel therapeutic target for the treatment of breast cancer by influencing growth, migration, invasion, and apoptosis of breast cancer cells via p38 MAPK signaling pathwaySong Park, Se-Hyeon Han, Hyeon-Gyeom Kim, et al.
BMC Pharmacology & Toxicology|July 28, 2016
Placental transfer and mammary excretion of a novel angiotensin receptor blocker fimasartan in ratsTae Hwan Kim, Min Gi Kim, Soyoung Shin, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 15, 2021
Administration in fed state but not controlled release in the colon increases oral bioavailability of DF030263, a promising drug candidate for chronic lymphocytic leukemiaJong Bong Lee, Xiaowei Zang, Atheer Zgair, et al.
Drug Delivery|June 13, 2018
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancerGa Hee Kim, Ji Eun Won, Yeongseon Byeon, et al.
Scientific Reports|December 3, 2016
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapyHee Dong Han, Yeongseon Byeon, Jong-Hwa Jang, et al.
Cancer Research|August 18, 2018
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian CancerYeongseon Byeon, Jeong-Won Lee, Whan Soo Choi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 18, 2018
Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic systemJong Bong Lee, Atheer Zgair, Jed Malec, et al.
Pageof 8